Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Takeshi Numoto Files to Sell 16,153 Microsoft Shares

Microsoft Corp officer Takeshi Numoto filed a Form 144 notice of proposed sale of 16,153 shares of Microsoft common stock, with a notice date of November 4, 2026 and an approximate sale date of November 5, 2026, through Fidelity Brokerage Services LLC on NASDAQ.

Aditi Sarkar | 05 November 2026

Orange County Bancorp Files Hovde Conference Slides

Orange County Bancorp, Inc. filed a Form 8-K on November 5, 2026, furnishing a slide presentation distributed to analysts and prospective investors at the 2026 Hovde Financial Services Conference.

Aditi Sarkar | 05 November 2026

JPMorgan Reports 8,964,843 DocuSign Shares at 4.5%

JPMorgan Chase & Co. filed an amended beneficial ownership statement with the SEC on November 5, 2026, disclosing a 4.5% stake in DocuSign, Inc. as of October 30, 2026.

Aditi Sarkar | 05 November 2026

JPMorgan Reports 4.3% Stake in Allegro MicroSystems

JPMorgan Chase & Co. filed an amended Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 8,022,860 shares of Allegro MicroSystems, Inc. common stock as of October 30, 2026.

Shwetambri Chauhan | 05 November 2026

JPMorgan Chase Reports 1.5% Stake in Levi Strauss Class A

JPMorgan Chase & Co. filed Amendment No. 2 to a Schedule 13G with the SEC on November 5, 2026, disclosing its beneficial ownership of Class A Common Stock of Levi Strauss & Co. as of October 30, 2026.

Anjali Anand | 05 November 2026

Why Did Katapult (NASDAQ:KPLT) Jump 113.46% in 1M, Ranking Among Top Small Cap Gainers?

Several mechanisms can drive such a move; this is general context, not a confirmed cause. First, a pending combination with Aaron's and CCF Holdings changes the expectedBusinessmix and share count, and arbitrage or event funds may trade the setup. Second, a lease-to-own and point-of-sale …

Vinay Lochav | 05 November 2026

Why Did Silence Therapeutics (NASDAQ:SLN) Surge 95.21% in 1M, Topping Small Cap Gainers?

Clinical data are the usual driver for a biotech. A randomized, placebo-controlled win in a rare blood disease lifts the probability of approval, brings a Phase 3 trial into view, and raises partnering interest. The company plans to start a Phase 3 quarterly dosing …

Vinay Lochav | 05 November 2026

Why Did Portillo's (NASDAQ:PTLO) Surge 86% in a Month, Topping Small Cap Gainers?

No single catalyst identified in the material reviewed, and the third quarter figures were not confirmed. General context: a restaurant stock that has fallen to the low end of its range can rebound sharply when short sellers cover, when earnings expectations are cut low …

Vinay Lochav | 05 November 2026

Why Did Universal Logistics (NASDAQ:ULH) Jump 84% in a Week, Topping Small Cap Gainers?

No single catalyst identified beyond the October 29, 2026 results, and consensus figures were not confirmed. The swing from a net loss of USD 117.938 million to a profit of USD 18.142 million is the clearest change, and a turnaround from a loss can …

Vinay Lochav | 05 November 2026

Why Did Grid Dynamics (NASDAQ:GDYN) Surge 74% in a Month, Topping Small Cap Gainers?

The catalyst was anEarningsbeat with fourth quarter profit guidance above consensus, tied to AI-driven delivery and productivity gains. Published coverage on October 30, 2026 described the shares as rocketing higher. General context: a company whose margins widen while revenue grows 9.7% can see estimates …

Vinay Lochav | 05 November 2026
Support

Hi! How can we help you today?

Loading…